Building Our Future

• Applying the science and moving product candidates for partners forward

• Protecting and improving our understanding of eligen™

• Building on current world-leadership position in oral delivery

  • Faster, higher throughput screening
  • Augmenting patent estate

• Continuing productivity enhancements:

  • 2002: Synthesized and screened 250 new EMISPHERE® delivery agents
  • As of September 2003: synthesized ~ 300 new carriers and evaluated > 1000 new EMISPHERE® delivery agents

Previous slide

Next slide

Back to first slide

View graphic version